Search
Feed aggregator
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS 3/21/2024
New Graduates Struggle in Current Biopharma Job Market
New Graduates Struggle in Current Biopharma Job Market 3/21/2024
Top 5 Remote Quality-Control Jobs
Top 5 Remote Quality-Control Jobs 3/21/2024
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
Bayer AG and Thermo Fisher Scientific Inc. today announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together. These will help identify patients who may benefit from Bayer's growing portfolio of precision cancer therapies by offering decentralized genomic testing and rapid turnaround time.
Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval
Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval 3/20/2024
BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche
BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche 3/20/2024
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B 3/20/2024
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers 3/20/2024
Historic Approval for MASH, CAR-Ts in the Spotlight
Historic Approval for MASH, CAR-Ts in the Spotlight 3/20/2024
What Another Trump Presidency Could Mean for Big Pharma
What Another Trump Presidency Could Mean for Big Pharma 3/20/2024
Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label
Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label 3/20/2024
How to Talk About Politics at Work
How to Talk About Politics at Work 3/20/2024
Novo Invests $556M in China Operations to Boost Manufacturing Capacity
Novo Invests $556M in China Operations to Boost Manufacturing Capacity 3/20/2024
Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA
Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA 3/20/2024
EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies
EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies 3/20/2024
Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC
Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA’s MASC 3/20/2024
With the Salary Growth Rate Slowing, Should Biopharma Employees Look for New Jobs?
With the Salary Growth Rate Slowing, Should Biopharma Employees Look for New Jobs? 3/20/2024
Cell therapy approach harnesses the immune system in a different way to stop cancer
A new cancer treatment that uses a person’s own immune cells has been approved by the U.S. Food and Drug Administration (FDA) for treating the most dangerous type of skin cancer. Now this form of cellular therapy (tumor-infiltrating lymphocyte - or TIL therapy) is showing promise in advanced lung cancers through clinical trials underway at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
AstraZeneca Buys Fusion in Potential $2B Deal, Joins Radiopharma Buying Spree
AstraZeneca Buys Fusion in Potential $2B Deal, Joins Radiopharma Buying Spree 3/19/2024
Bayer’s Veozah Rival Hits Goals in Long-Term Phase III Hot Flash Study
Bayer’s Veozah Rival Hits Goals in Long-Term Phase III Hot Flash Study 3/19/2024
World Pharma News
- Researchers develop a new way to safely boost immune cells to fight cancer
- How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Common HIV treatments may aid Alzheimer's disease patients
- AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson's disease
- Next-generation treatments hitch a ride into cancer cells